Similar articles for PMID: 17042764

Year	Number of Results
1963	1
1975	1
1980	1
1982	1
1986	1
1988	1
1990	1
1991	2
1993	1
1994	2
1995	1
1997	3
1998	4
1999	6
2000	4
2001	11
2002	10
2003	12
2004	12
2005	6
2006	14
2007	13
2008	23
2009	27
2010	17
2011	11
2012	8
2013	14
2014	12
2015	13
2016	9
2017	11
2018	9
2019	7
2020	14
2021	11
2022	11
2023	2
2024	0

1

Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.

Sconce EA, Kamali F. Sconce EA, et al. Eur J Haematol. 2006 Dec;77(6):457-62. doi: 10.1111/j.0902-4441.2006.t01-1-EJH2957.x. Epub 2006 Oct 17. Eur J Haematol. 2006. PMID: 17042764 Review.

2

Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.

Kampouraki E, Avery PJ, Wynne H, Biss T, Hanley J, Talks K, Kamali F. Kampouraki E, et al. Br J Haematol. 2017 Sep;178(5):800-809. doi: 10.1111/bjh.14777. Epub 2017 Aug 2. Br J Haematol. 2017. PMID: 28771671 Free article. Clinical Trial.

3

Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.

Bussey HI, Bussey M, Bussey-Smith KL, Frei CR. Bussey HI, et al. Pharmacotherapy. 2013 Nov;33(11):1136-46. doi: 10.1002/phar.1343. Epub 2013 Aug 22. Pharmacotherapy. 2013. PMID: 24038412

4

The pharmocogenomics of warfarin: closing in on personalized medicine.

Rettie AE, Tai G. Rettie AE, et al. Mol Interv. 2006 Aug;6(4):223-7. doi: 10.1124/mi.6.4.8. Mol Interv. 2006. PMID: 16960144 Review.

5

Warfarin anticoagulation in children: is there a role for a personalized approach to dosing?

Biss TT, Kamali F. Biss TT, et al. Pharmacogenomics. 2012 Aug;13(11):1211-4. doi: 10.2217/pgs.12.92. Pharmacogenomics. 2012. PMID: 22920389 No abstract available.

6

Algorithms using clinical and genetic data (CYP2C9, VKORC1) are relevant to predict warfarin dose in patients with different INR targets.

Le Cam-Duchez V, Frétigny M, Cailleux N, Gandelin C, Lévesque H, Borg JY. Le Cam-Duchez V, et al. Thromb Res. 2010 Sep;126(3):e235-7. doi: 10.1016/j.thromres.2010.05.003. Epub 2010 May 31. Thromb Res. 2010. PMID: 20569971 Clinical Trial. No abstract available.

7

Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.

Shaw PB, Donovan JL, Tran MT, Lemon SC, Burgwinkle P, Gore J. Shaw PB, et al. J Thromb Thrombolysis. 2010 Aug;30(2):220-5. doi: 10.1007/s11239-010-0459-3. J Thromb Thrombolysis. 2010. PMID: 20204461

8

Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.

Oldenburg J, Bevans CG, Fregin A, Geisen C, Müller-Reible C, Watzka M. Oldenburg J, et al. Thromb Haemost. 2007 Sep;98(3):570-8. Thromb Haemost. 2007. PMID: 17849045 Review.

9

Genetic testing for warfarin dosing? Not yet ready for prime time.

Bussey HI, Wittkowsky AK, Hylek EM, Walker MB. Bussey HI, et al. Pharmacotherapy. 2008 Feb;28(2):141-3. doi: 10.1592/phco.28.2.141. Pharmacotherapy. 2008. PMID: 18225960 No abstract available.

10

Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy.

You JH, Tsui KK, Wong RS, Cheng G. You JH, et al. Clin Pharmacol Ther. 2009 Nov;86(5):540-7. doi: 10.1038/clpt.2009.104. Epub 2009 Jul 1. Clin Pharmacol Ther. 2009. PMID: 19571807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

288 results

Results by year